nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—BCHE—Irinotecan—lung cancer	0.381	0.551	CbGbCtD
Terbutaline—BCHE—Cisplatin—lung cancer	0.31	0.449	CbGbCtD
Terbutaline—BCHE—diaphragm—lung cancer	0.0227	0.649	CbGeAlD
Terbutaline—Allergic cutaneous angiitis—Methotrexate—lung cancer	0.00493	0.0189	CcSEcCtD
Terbutaline—Injection site pain—Vinorelbine—lung cancer	0.00468	0.018	CcSEcCtD
Terbutaline—Sweating—Teniposide—lung cancer	0.00323	0.0124	CcSEcCtD
Terbutaline—Leukocytoclastic vasculitis—Methotrexate—lung cancer	0.0032	0.0123	CcSEcCtD
Terbutaline—Chest discomfort—Etoposide—lung cancer	0.00296	0.0114	CcSEcCtD
Terbutaline—Cramp muscle—Topotecan—lung cancer	0.00292	0.0112	CcSEcCtD
Terbutaline—Chest discomfort—Paclitaxel—lung cancer	0.0029	0.0111	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Paclitaxel—lung cancer	0.00284	0.0109	CcSEcCtD
Terbutaline—Flushing—Teniposide—lung cancer	0.00281	0.0108	CcSEcCtD
Terbutaline—Chest pain—Pemetrexed—lung cancer	0.00277	0.0106	CcSEcCtD
Terbutaline—Dry mouth—Gefitinib—lung cancer	0.00269	0.0103	CcSEcCtD
Terbutaline—Paraesthesia—Crizotinib—lung cancer	0.00261	0.01	CcSEcCtD
Terbutaline—BCHE—respiratory system—lung cancer	0.0026	0.0741	CbGeAlD
Terbutaline—Dyspnoea—Crizotinib—lung cancer	0.00259	0.00993	CcSEcCtD
Terbutaline—Chest discomfort—Docetaxel—lung cancer	0.00246	0.00944	CcSEcCtD
Terbutaline—Sweating—Topotecan—lung cancer	0.00239	0.00919	CcSEcCtD
Terbutaline—Dyspnoea—Pemetrexed—lung cancer	0.00236	0.00908	CcSEcCtD
Terbutaline—Dyspnoea—Gefitinib—lung cancer	0.00235	0.00902	CcSEcCtD
Terbutaline—Hypertonia—Paclitaxel—lung cancer	0.00225	0.00864	CcSEcCtD
Terbutaline—Chest pain—Teniposide—lung cancer	0.00224	0.0086	CcSEcCtD
Terbutaline—BCHE—bronchus—lung cancer	0.00214	0.061	CbGeAlD
Terbutaline—Tachycardia—Teniposide—lung cancer	0.0021	0.00805	CcSEcCtD
Terbutaline—Asthenia—Crizotinib—lung cancer	0.00208	0.00799	CcSEcCtD
Terbutaline—Hyperhidrosis—Teniposide—lung cancer	0.00208	0.00797	CcSEcCtD
Terbutaline—Cramp muscle—Irinotecan—lung cancer	0.00206	0.0079	CcSEcCtD
Terbutaline—Dizziness—Crizotinib—lung cancer	0.00192	0.00737	CcSEcCtD
Terbutaline—BCHE—trachea—lung cancer	0.00192	0.0548	CbGeAlD
Terbutaline—Dyspnoea—Teniposide—lung cancer	0.00192	0.00735	CcSEcCtD
Terbutaline—Asthenia—Pemetrexed—lung cancer	0.0019	0.00731	CcSEcCtD
Terbutaline—Asthenia—Gefitinib—lung cancer	0.00189	0.00726	CcSEcCtD
Terbutaline—Muscle spasms—Topotecan—lung cancer	0.00188	0.0072	CcSEcCtD
Terbutaline—Cramp muscle—Cisplatin—lung cancer	0.00187	0.00717	CcSEcCtD
Terbutaline—Vomiting—Crizotinib—lung cancer	0.00185	0.00708	CcSEcCtD
Terbutaline—Rash—Crizotinib—lung cancer	0.00183	0.00703	CcSEcCtD
Terbutaline—Dermatitis—Crizotinib—lung cancer	0.00183	0.00702	CcSEcCtD
Terbutaline—BCHE—cardiac atrium—lung cancer	0.0018	0.0514	CbGeAlD
Terbutaline—Flushing—Vinorelbine—lung cancer	0.00178	0.00683	CcSEcCtD
Terbutaline—Dizziness—Pemetrexed—lung cancer	0.00175	0.00673	CcSEcCtD
Terbutaline—Nausea—Crizotinib—lung cancer	0.00172	0.00662	CcSEcCtD
Terbutaline—Cramp muscle—Etoposide—lung cancer	0.00171	0.00657	CcSEcCtD
Terbutaline—Sweating—Irinotecan—lung cancer	0.00169	0.00648	CcSEcCtD
Terbutaline—Vomiting—Pemetrexed—lung cancer	0.00169	0.00647	CcSEcCtD
Terbutaline—Cramp muscle—Paclitaxel—lung cancer	0.00168	0.00644	CcSEcCtD
Terbutaline—Vomiting—Gefitinib—lung cancer	0.00168	0.00643	CcSEcCtD
Terbutaline—Rash—Pemetrexed—lung cancer	0.00167	0.00642	CcSEcCtD
Terbutaline—Dermatitis—Pemetrexed—lung cancer	0.00167	0.00641	CcSEcCtD
Terbutaline—Injection site pain—Doxorubicin—lung cancer	0.00166	0.00639	CcSEcCtD
Terbutaline—Rash—Gefitinib—lung cancer	0.00166	0.00638	CcSEcCtD
Terbutaline—Chest pain—Topotecan—lung cancer	0.00166	0.00638	CcSEcCtD
Terbutaline—Dermatitis—Gefitinib—lung cancer	0.00166	0.00637	CcSEcCtD
Terbutaline—Sweating—Gemcitabine—lung cancer	0.00165	0.00632	CcSEcCtD
Terbutaline—Chest pain—Erlotinib—lung cancer	0.00164	0.00631	CcSEcCtD
Terbutaline—Anxiety—Erlotinib—lung cancer	0.00164	0.00629	CcSEcCtD
Terbutaline—Nausea—Pemetrexed—lung cancer	0.00158	0.00605	CcSEcCtD
Terbutaline—Nausea—Gefitinib—lung cancer	0.00157	0.00601	CcSEcCtD
Terbutaline—Asthenia—Teniposide—lung cancer	0.00154	0.00592	CcSEcCtD
Terbutaline—Hyperhidrosis—Topotecan—lung cancer	0.00154	0.00591	CcSEcCtD
Terbutaline—BCHE—bone marrow—lung cancer	0.00152	0.0434	CbGeAlD
Terbutaline—Ventricular extrasystoles—Doxorubicin—lung cancer	0.0015	0.00577	CcSEcCtD
Terbutaline—Palpitations—Vinorelbine—lung cancer	0.00148	0.00566	CcSEcCtD
Terbutaline—Paraesthesia—Vinblastine—lung cancer	0.00147	0.00565	CcSEcCtD
Terbutaline—Flushing—Irinotecan—lung cancer	0.00147	0.00563	CcSEcCtD
Terbutaline—Paraesthesia—Topotecan—lung cancer	0.00143	0.00549	CcSEcCtD
Terbutaline—Insomnia—Erlotinib—lung cancer	0.00142	0.00547	CcSEcCtD
Terbutaline—Cramp muscle—Docetaxel—lung cancer	0.00142	0.00546	CcSEcCtD
Terbutaline—Chest pain—Vinorelbine—lung cancer	0.00142	0.00546	CcSEcCtD
Terbutaline—Dyspnoea—Topotecan—lung cancer	0.00142	0.00545	CcSEcCtD
Terbutaline—Dyspnoea—Erlotinib—lung cancer	0.0014	0.00539	CcSEcCtD
Terbutaline—BCHE—lung—lung cancer	0.00138	0.0393	CbGeAlD
Terbutaline—Vomiting—Teniposide—lung cancer	0.00137	0.00524	CcSEcCtD
Terbutaline—Rash—Teniposide—lung cancer	0.00135	0.0052	CcSEcCtD
Terbutaline—Dermatitis—Teniposide—lung cancer	0.00135	0.0052	CcSEcCtD
Terbutaline—Headache—Teniposide—lung cancer	0.00135	0.00517	CcSEcCtD
Terbutaline—Flushing—Cisplatin—lung cancer	0.00133	0.00512	CcSEcCtD
Terbutaline—Tachycardia—Vinorelbine—lung cancer	0.00133	0.0051	CcSEcCtD
Terbutaline—Muscle spasms—Irinotecan—lung cancer	0.00132	0.00508	CcSEcCtD
Terbutaline—Nausea—Teniposide—lung cancer	0.00128	0.0049	CcSEcCtD
Terbutaline—Paraesthesia—Vinorelbine—lung cancer	0.00122	0.0047	CcSEcCtD
Terbutaline—Flushing—Etoposide—lung cancer	0.00122	0.00469	CcSEcCtD
Terbutaline—Dyspnoea—Vinorelbine—lung cancer	0.00121	0.00466	CcSEcCtD
Terbutaline—Muscle spasms—Cisplatin—lung cancer	0.0012	0.00461	CcSEcCtD
Terbutaline—Flushing—Paclitaxel—lung cancer	0.0012	0.0046	CcSEcCtD
Terbutaline—Hypertonia—Doxorubicin—lung cancer	0.00119	0.00457	CcSEcCtD
Terbutaline—Asthenia—Vinblastine—lung cancer	0.00118	0.00452	CcSEcCtD
Terbutaline—Tremor—Cisplatin—lung cancer	0.00117	0.0045	CcSEcCtD
Terbutaline—Asthenia—Topotecan—lung cancer	0.00114	0.00439	CcSEcCtD
Terbutaline—Chest pain—Gemcitabine—lung cancer	0.00114	0.00438	CcSEcCtD
Terbutaline—Asthenia—Erlotinib—lung cancer	0.00113	0.00434	CcSEcCtD
Terbutaline—Tension—Paclitaxel—lung cancer	0.0011	0.00423	CcSEcCtD
Terbutaline—Muscle spasms—Etoposide—lung cancer	0.0011	0.00423	CcSEcCtD
Terbutaline—Nervousness—Paclitaxel—lung cancer	0.00109	0.00419	CcSEcCtD
Terbutaline—Hyperhidrosis—Irinotecan—lung cancer	0.00109	0.00417	CcSEcCtD
Terbutaline—Dizziness—Vinblastine—lung cancer	0.00108	0.00416	CcSEcCtD
Terbutaline—Muscle spasms—Paclitaxel—lung cancer	0.00108	0.00414	CcSEcCtD
Terbutaline—Clenbuterol—CYP1A1—lung cancer	0.00108	0.667	CrCbGaD
Terbutaline—Anxiety—Cisplatin—lung cancer	0.00106	0.00407	CcSEcCtD
Terbutaline—Hyperhidrosis—Gemcitabine—lung cancer	0.00106	0.00406	CcSEcCtD
Terbutaline—Dizziness—Topotecan—lung cancer	0.00105	0.00404	CcSEcCtD
Terbutaline—Tremor—Paclitaxel—lung cancer	0.00105	0.00404	CcSEcCtD
Terbutaline—Vomiting—Vinblastine—lung cancer	0.00104	0.004	CcSEcCtD
Terbutaline—Dizziness—Erlotinib—lung cancer	0.00104	0.004	CcSEcCtD
Terbutaline—Headache—Vinblastine—lung cancer	0.00103	0.00394	CcSEcCtD
Terbutaline—Insomnia—Irinotecan—lung cancer	0.00102	0.0039	CcSEcCtD
Terbutaline—Flushing—Docetaxel—lung cancer	0.00101	0.00389	CcSEcCtD
Terbutaline—Vomiting—Topotecan—lung cancer	0.00101	0.00389	CcSEcCtD
Terbutaline—Paraesthesia—Irinotecan—lung cancer	0.00101	0.00387	CcSEcCtD
Terbutaline—Rash—Topotecan—lung cancer	0.001	0.00385	CcSEcCtD
Terbutaline—Dermatitis—Topotecan—lung cancer	0.001	0.00385	CcSEcCtD
Terbutaline—Vomiting—Erlotinib—lung cancer	0.001	0.00385	CcSEcCtD
Terbutaline—Dyspnoea—Irinotecan—lung cancer	0.001	0.00385	CcSEcCtD
Terbutaline—Somnolence—Irinotecan—lung cancer	0.000999	0.00383	CcSEcCtD
Terbutaline—Headache—Topotecan—lung cancer	0.000998	0.00383	CcSEcCtD
Terbutaline—Tachycardia—Cisplatin—lung cancer	0.000996	0.00382	CcSEcCtD
Terbutaline—Rash—Erlotinib—lung cancer	0.000993	0.00381	CcSEcCtD
Terbutaline—Dermatitis—Erlotinib—lung cancer	0.000992	0.00381	CcSEcCtD
Terbutaline—Palpitations—Paclitaxel—lung cancer	0.000992	0.00381	CcSEcCtD
Terbutaline—Insomnia—Gemcitabine—lung cancer	0.00099	0.0038	CcSEcCtD
Terbutaline—Headache—Erlotinib—lung cancer	0.000987	0.00379	CcSEcCtD
Terbutaline—Hyperhidrosis—Cisplatin—lung cancer	0.000986	0.00379	CcSEcCtD
Terbutaline—Paraesthesia—Gemcitabine—lung cancer	0.000983	0.00377	CcSEcCtD
Terbutaline—Asthenia—Vinorelbine—lung cancer	0.000977	0.00375	CcSEcCtD
Terbutaline—Dyspnoea—Gemcitabine—lung cancer	0.000976	0.00375	CcSEcCtD
Terbutaline—Chest pain—Etoposide—lung cancer	0.000975	0.00374	CcSEcCtD
Terbutaline—Nausea—Vinblastine—lung cancer	0.000974	0.00374	CcSEcCtD
Terbutaline—Somnolence—Gemcitabine—lung cancer	0.000973	0.00374	CcSEcCtD
Terbutaline—Chest pain—Paclitaxel—lung cancer	0.000956	0.00367	CcSEcCtD
Terbutaline—Anxiety—Paclitaxel—lung cancer	0.000952	0.00366	CcSEcCtD
Terbutaline—Nausea—Topotecan—lung cancer	0.000946	0.00363	CcSEcCtD
Terbutaline—BCHE—lymph node—lung cancer	0.000943	0.0269	CbGeAlD
Terbutaline—Nausea—Erlotinib—lung cancer	0.000936	0.00359	CcSEcCtD
Terbutaline—Dry mouth—Paclitaxel—lung cancer	0.000935	0.00359	CcSEcCtD
Terbutaline—Paraesthesia—Cisplatin—lung cancer	0.000916	0.00352	CcSEcCtD
Terbutaline—Muscle spasms—Docetaxel—lung cancer	0.000915	0.00351	CcSEcCtD
Terbutaline—Tachycardia—Etoposide—lung cancer	0.000912	0.0035	CcSEcCtD
Terbutaline—Dyspnoea—Cisplatin—lung cancer	0.000909	0.00349	CcSEcCtD
Terbutaline—Hyperhidrosis—Etoposide—lung cancer	0.000903	0.00347	CcSEcCtD
Terbutaline—Dizziness—Vinorelbine—lung cancer	0.000901	0.00346	CcSEcCtD
Terbutaline—Tachycardia—Paclitaxel—lung cancer	0.000894	0.00343	CcSEcCtD
Terbutaline—Hyperhidrosis—Paclitaxel—lung cancer	0.000886	0.0034	CcSEcCtD
Terbutaline—Drowsiness—Methotrexate—lung cancer	0.000878	0.00337	CcSEcCtD
Terbutaline—Vomiting—Vinorelbine—lung cancer	0.000866	0.00333	CcSEcCtD
Terbutaline—Rash—Vinorelbine—lung cancer	0.000859	0.0033	CcSEcCtD
Terbutaline—Dermatitis—Vinorelbine—lung cancer	0.000858	0.00329	CcSEcCtD
Terbutaline—Headache—Vinorelbine—lung cancer	0.000853	0.00328	CcSEcCtD
Terbutaline—Sweating—Methotrexate—lung cancer	0.000841	0.00323	CcSEcCtD
Terbutaline—Palpitations—Docetaxel—lung cancer	0.000841	0.00323	CcSEcCtD
Terbutaline—Paraesthesia—Etoposide—lung cancer	0.000839	0.00322	CcSEcCtD
Terbutaline—Dyspnoea—Etoposide—lung cancer	0.000833	0.0032	CcSEcCtD
Terbutaline—Somnolence—Etoposide—lung cancer	0.000831	0.00319	CcSEcCtD
Terbutaline—Insomnia—Paclitaxel—lung cancer	0.000829	0.00318	CcSEcCtD
Terbutaline—Paraesthesia—Paclitaxel—lung cancer	0.000823	0.00316	CcSEcCtD
Terbutaline—Dyspnoea—Paclitaxel—lung cancer	0.000817	0.00314	CcSEcCtD
Terbutaline—Somnolence—Paclitaxel—lung cancer	0.000815	0.00313	CcSEcCtD
Terbutaline—Chest pain—Docetaxel—lung cancer	0.00081	0.00311	CcSEcCtD
Terbutaline—Nausea—Vinorelbine—lung cancer	0.000809	0.00311	CcSEcCtD
Terbutaline—Asthenia—Irinotecan—lung cancer	0.000806	0.00309	CcSEcCtD
Terbutaline—Dry mouth—Docetaxel—lung cancer	0.000792	0.00304	CcSEcCtD
Terbutaline—Asthenia—Gemcitabine—lung cancer	0.000785	0.00301	CcSEcCtD
Terbutaline—Drowsiness—Doxorubicin—lung cancer	0.00076	0.00292	CcSEcCtD
Terbutaline—Tachycardia—Docetaxel—lung cancer	0.000758	0.00291	CcSEcCtD
Terbutaline—Dizziness—Irinotecan—lung cancer	0.000743	0.00285	CcSEcCtD
Terbutaline—Asthenia—Cisplatin—lung cancer	0.000732	0.00281	CcSEcCtD
Terbutaline—Sweating—Doxorubicin—lung cancer	0.000729	0.0028	CcSEcCtD
Terbutaline—Vomiting—Irinotecan—lung cancer	0.000714	0.00274	CcSEcCtD
Terbutaline—Rash—Irinotecan—lung cancer	0.000708	0.00272	CcSEcCtD
Terbutaline—Dermatitis—Irinotecan—lung cancer	0.000708	0.00272	CcSEcCtD
Terbutaline—Headache—Irinotecan—lung cancer	0.000704	0.0027	CcSEcCtD
Terbutaline—Insomnia—Docetaxel—lung cancer	0.000702	0.0027	CcSEcCtD
Terbutaline—Paraesthesia—Docetaxel—lung cancer	0.000697	0.00268	CcSEcCtD
Terbutaline—Vomiting—Gemcitabine—lung cancer	0.000696	0.00267	CcSEcCtD
Terbutaline—Dyspnoea—Docetaxel—lung cancer	0.000692	0.00266	CcSEcCtD
Terbutaline—Somnolence—Docetaxel—lung cancer	0.00069	0.00265	CcSEcCtD
Terbutaline—Rash—Gemcitabine—lung cancer	0.00069	0.00265	CcSEcCtD
Terbutaline—Dermatitis—Gemcitabine—lung cancer	0.000689	0.00265	CcSEcCtD
Terbutaline—Headache—Gemcitabine—lung cancer	0.000686	0.00263	CcSEcCtD
Terbutaline—Asthenia—Etoposide—lung cancer	0.00067	0.00257	CcSEcCtD
Terbutaline—Nausea—Irinotecan—lung cancer	0.000667	0.00256	CcSEcCtD
Terbutaline—Asthenia—Paclitaxel—lung cancer	0.000657	0.00252	CcSEcCtD
Terbutaline—Nausea—Gemcitabine—lung cancer	0.00065	0.0025	CcSEcCtD
Terbutaline—Vomiting—Cisplatin—lung cancer	0.000649	0.00249	CcSEcCtD
Terbutaline—Rash—Cisplatin—lung cancer	0.000643	0.00247	CcSEcCtD
Terbutaline—Dermatitis—Cisplatin—lung cancer	0.000643	0.00247	CcSEcCtD
Terbutaline—Flushing—Doxorubicin—lung cancer	0.000633	0.00243	CcSEcCtD
Terbutaline—Dizziness—Etoposide—lung cancer	0.000618	0.00237	CcSEcCtD
Terbutaline—Dizziness—Paclitaxel—lung cancer	0.000606	0.00233	CcSEcCtD
Terbutaline—Nausea—Cisplatin—lung cancer	0.000606	0.00233	CcSEcCtD
Terbutaline—Vomiting—Etoposide—lung cancer	0.000594	0.00228	CcSEcCtD
Terbutaline—Rash—Etoposide—lung cancer	0.000589	0.00226	CcSEcCtD
Terbutaline—Dermatitis—Etoposide—lung cancer	0.000589	0.00226	CcSEcCtD
Terbutaline—Headache—Etoposide—lung cancer	0.000585	0.00225	CcSEcCtD
Terbutaline—Chest pain—Methotrexate—lung cancer	0.000584	0.00224	CcSEcCtD
Terbutaline—Tension—Doxorubicin—lung cancer	0.000583	0.00224	CcSEcCtD
Terbutaline—Vomiting—Paclitaxel—lung cancer	0.000583	0.00224	CcSEcCtD
Terbutaline—Rash—Paclitaxel—lung cancer	0.000578	0.00222	CcSEcCtD
Terbutaline—Dermatitis—Paclitaxel—lung cancer	0.000577	0.00222	CcSEcCtD
Terbutaline—Nervousness—Doxorubicin—lung cancer	0.000577	0.00221	CcSEcCtD
Terbutaline—Headache—Paclitaxel—lung cancer	0.000574	0.0022	CcSEcCtD
Terbutaline—Muscle spasms—Doxorubicin—lung cancer	0.000571	0.00219	CcSEcCtD
Terbutaline—Asthenia—Docetaxel—lung cancer	0.000557	0.00214	CcSEcCtD
Terbutaline—Nausea—Etoposide—lung cancer	0.000555	0.00213	CcSEcCtD
Terbutaline—Nausea—Paclitaxel—lung cancer	0.000544	0.00209	CcSEcCtD
Terbutaline—Hyperhidrosis—Methotrexate—lung cancer	0.000541	0.00208	CcSEcCtD
Terbutaline—Isoprenaline—CYP1A1—lung cancer	0.000538	0.333	CrCbGaD
Terbutaline—Palpitations—Doxorubicin—lung cancer	0.000525	0.00201	CcSEcCtD
Terbutaline—Dizziness—Docetaxel—lung cancer	0.000514	0.00197	CcSEcCtD
Terbutaline—Insomnia—Methotrexate—lung cancer	0.000506	0.00194	CcSEcCtD
Terbutaline—Chest pain—Doxorubicin—lung cancer	0.000506	0.00194	CcSEcCtD
Terbutaline—Anxiety—Doxorubicin—lung cancer	0.000504	0.00193	CcSEcCtD
Terbutaline—Paraesthesia—Methotrexate—lung cancer	0.000503	0.00193	CcSEcCtD
Terbutaline—Dyspnoea—Methotrexate—lung cancer	0.000499	0.00192	CcSEcCtD
Terbutaline—Somnolence—Methotrexate—lung cancer	0.000498	0.00191	CcSEcCtD
Terbutaline—Dry mouth—Doxorubicin—lung cancer	0.000494	0.0019	CcSEcCtD
Terbutaline—Vomiting—Docetaxel—lung cancer	0.000494	0.0019	CcSEcCtD
Terbutaline—Rash—Docetaxel—lung cancer	0.00049	0.00188	CcSEcCtD
Terbutaline—Dermatitis—Docetaxel—lung cancer	0.000489	0.00188	CcSEcCtD
Terbutaline—Headache—Docetaxel—lung cancer	0.000487	0.00187	CcSEcCtD
Terbutaline—Tachycardia—Doxorubicin—lung cancer	0.000473	0.00182	CcSEcCtD
Terbutaline—Hyperhidrosis—Doxorubicin—lung cancer	0.000469	0.0018	CcSEcCtD
Terbutaline—Nausea—Docetaxel—lung cancer	0.000461	0.00177	CcSEcCtD
Terbutaline—Insomnia—Doxorubicin—lung cancer	0.000438	0.00168	CcSEcCtD
Terbutaline—Paraesthesia—Doxorubicin—lung cancer	0.000435	0.00167	CcSEcCtD
Terbutaline—Dyspnoea—Doxorubicin—lung cancer	0.000432	0.00166	CcSEcCtD
Terbutaline—Somnolence—Doxorubicin—lung cancer	0.000431	0.00165	CcSEcCtD
Terbutaline—Asthenia—Methotrexate—lung cancer	0.000402	0.00154	CcSEcCtD
Terbutaline—Dizziness—Methotrexate—lung cancer	0.00037	0.00142	CcSEcCtD
Terbutaline—Vomiting—Methotrexate—lung cancer	0.000356	0.00137	CcSEcCtD
Terbutaline—Rash—Methotrexate—lung cancer	0.000353	0.00135	CcSEcCtD
Terbutaline—Dermatitis—Methotrexate—lung cancer	0.000353	0.00135	CcSEcCtD
Terbutaline—Headache—Methotrexate—lung cancer	0.000351	0.00135	CcSEcCtD
Terbutaline—Asthenia—Doxorubicin—lung cancer	0.000348	0.00134	CcSEcCtD
Terbutaline—Nausea—Methotrexate—lung cancer	0.000332	0.00128	CcSEcCtD
Terbutaline—Dizziness—Doxorubicin—lung cancer	0.000321	0.00123	CcSEcCtD
Terbutaline—Vomiting—Doxorubicin—lung cancer	0.000308	0.00118	CcSEcCtD
Terbutaline—Rash—Doxorubicin—lung cancer	0.000306	0.00117	CcSEcCtD
Terbutaline—Dermatitis—Doxorubicin—lung cancer	0.000305	0.00117	CcSEcCtD
Terbutaline—Headache—Doxorubicin—lung cancer	0.000304	0.00117	CcSEcCtD
Terbutaline—Nausea—Doxorubicin—lung cancer	0.000288	0.00111	CcSEcCtD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY1—lung cancer	0.000104	0.00865	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—GNG11—lung cancer	9.96e-05	0.00828	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—CHRNA5—lung cancer	9.9e-05	0.00823	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 signaling events—SRC—lung cancer	9.16e-05	0.00762	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—ADCY1—lung cancer	8.95e-05	0.00745	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	8.68e-05	0.00722	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—EIF2B4—lung cancer	8.42e-05	0.007	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—CHRNA3—lung cancer	8.07e-05	0.00671	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 signaling events—EGFR—lung cancer	8.02e-05	0.00668	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—OXTR—lung cancer	7.97e-05	0.00663	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—AVP—lung cancer	7.76e-05	0.00646	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—GNG11—lung cancer	7.63e-05	0.00635	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—POMC—lung cancer	7.6e-05	0.00632	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GIPR—lung cancer	7.42e-05	0.00617	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—KHSRP—lung cancer	6.86e-05	0.00571	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—ADCY1—lung cancer	6.86e-05	0.00571	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—OXTR—lung cancer	6.82e-05	0.00568	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—GRP—lung cancer	6.82e-05	0.00568	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	6.75e-05	0.00562	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—KIF5B—lung cancer	6.61e-05	0.0055	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GRM8—lung cancer	6.31e-05	0.00525	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—EIF2B5—lung cancer	6e-05	0.00499	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CG—lung cancer	5.42e-05	0.00451	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GRP—lung cancer	5.2e-05	0.00432	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—OXTR—lung cancer	5.2e-05	0.00432	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—POMC—lung cancer	5.16e-05	0.00429	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AZIN2—lung cancer	5.1e-05	0.00424	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—COL4A3BP—lung cancer	5.1e-05	0.00424	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ST3GAL5—lung cancer	5.1e-05	0.00424	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	5.02e-05	0.00418	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GNG11—lung cancer	4.86e-05	0.00405	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CD—lung cancer	4.76e-05	0.00396	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	4.76e-05	0.00396	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.76e-05	0.00396	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.61e-05	0.00383	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ADAMTS1—lung cancer	4.55e-05	0.00378	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—B4GALT5—lung cancer	4.55e-05	0.00378	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ATP5H—lung cancer	4.34e-05	0.00361	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GIPR—lung cancer	4.19e-05	0.00349	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CB—lung cancer	4.15e-05	0.00345	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PTHLH—lung cancer	4.07e-05	0.00338	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.99e-05	0.00332	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—GRP—lung cancer	3.98e-05	0.00331	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLBD1—lung cancer	3.87e-05	0.00322	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—ANXA1—lung cancer	3.82e-05	0.00318	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GIPR—lung cancer	3.81e-05	0.00317	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.8e-05	0.00316	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—BRAF—lung cancer	3.79e-05	0.00315	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	3.7e-05	0.00308	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—APP—lung cancer	3.62e-05	0.00302	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PTEN—lung cancer	3.59e-05	0.00298	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRM8—lung cancer	3.57e-05	0.00297	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD17B10—lung cancer	3.54e-05	0.00294	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ATF3—lung cancer	3.47e-05	0.00289	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CKB—lung cancer	3.29e-05	0.00274	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRM8—lung cancer	3.24e-05	0.00269	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—MDM2—lung cancer	3.17e-05	0.00264	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—RAF1—lung cancer	3.16e-05	0.00263	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—LMNA—lung cancer	3.12e-05	0.00259	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CNDP2—lung cancer	3.09e-05	0.00257	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTM2—lung cancer	3.09e-05	0.00257	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTMR3—lung cancer	3.01e-05	0.0025	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AXL—lung cancer	2.97e-05	0.00247	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—OXTR—lung cancer	2.94e-05	0.00244	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRP—lung cancer	2.94e-05	0.00244	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PGAM1—lung cancer	2.93e-05	0.00244	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—BRAF—lung cancer	2.9e-05	0.00241	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—AVP—lung cancer	2.82e-05	0.00234	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2A7—lung cancer	2.8e-05	0.00233	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GNG11—lung cancer	2.75e-05	0.00229	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SDC4—lung cancer	2.74e-05	0.00228	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—OXTR—lung cancer	2.67e-05	0.00222	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRP—lung cancer	2.67e-05	0.00222	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CA—lung cancer	2.53e-05	0.00211	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GNG11—lung cancer	2.5e-05	0.00208	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA3—lung cancer	2.49e-05	0.00207	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—RRM1—lung cancer	2.49e-05	0.00207	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADCY1—lung cancer	2.47e-05	0.00206	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	2.46e-05	0.00205	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—MDM2—lung cancer	2.43e-05	0.00202	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—RAF1—lung cancer	2.42e-05	0.00201	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—B4GALT5—lung cancer	2.34e-05	0.00195	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—COL4A2—lung cancer	2.31e-05	0.00192	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PTHLH—lung cancer	2.3e-05	0.00191	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA4—lung cancer	2.28e-05	0.0019	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GIPR—lung cancer	2.25e-05	0.00187	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADCY1—lung cancer	2.24e-05	0.00187	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.23e-05	0.00185	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA2—lung cancer	2.22e-05	0.00185	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PPP2R1B—lung cancer	2.19e-05	0.00182	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ANXA1—lung cancer	2.16e-05	0.0018	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA1—lung cancer	2.14e-05	0.00178	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCC3—lung cancer	2.12e-05	0.00176	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SDC4—lung cancer	2.1e-05	0.00175	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTHLH—lung cancer	2.09e-05	0.00174	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DUSP3—lung cancer	2.06e-05	0.00171	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKR1C1—lung cancer	2.05e-05	0.00171	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—APP—lung cancer	2.05e-05	0.0017	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RHEB—lung cancer	2.02e-05	0.00168	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—UGT1A1—lung cancer	1.99e-05	0.00166	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ANXA1—lung cancer	1.96e-05	0.00163	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GNG11—lung cancer	1.92e-05	0.0016	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRM8—lung cancer	1.91e-05	0.00159	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.91e-05	0.00159	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	1.9e-05	0.00158	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—POMC—lung cancer	1.87e-05	0.00156	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—APP—lung cancer	1.86e-05	0.00155	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SKI—lung cancer	1.85e-05	0.00154	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALDOA—lung cancer	1.83e-05	0.00152	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA3—lung cancer	1.78e-05	0.00148	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.74e-05	0.00145	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	1.74e-05	0.00145	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCG2—lung cancer	1.73e-05	0.00144	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ADCY1—lung cancer	1.73e-05	0.00144	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP1—lung cancer	1.73e-05	0.00144	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HPGDS—lung cancer	1.69e-05	0.00141	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ENO2—lung cancer	1.69e-05	0.00141	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPP2R1B—lung cancer	1.68e-05	0.0014	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.66e-05	0.00138	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTT1—lung cancer	1.64e-05	0.00137	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GCLC—lung cancer	1.62e-05	0.00135	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2A6—lung cancer	1.62e-05	0.00135	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.62e-05	0.00135	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PXN—lung cancer	1.61e-05	0.00134	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AVP—lung cancer	1.59e-05	0.00133	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRP—lung cancer	1.58e-05	0.00131	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKR1C1—lung cancer	1.58e-05	0.00131	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—OXTR—lung cancer	1.58e-05	0.00131	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ENO1—lung cancer	1.54e-05	0.00128	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.53e-05	0.00128	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.51e-05	0.00126	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNG11—lung cancer	1.47e-05	0.00123	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CXCL8—lung cancer	1.45e-05	0.00121	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AVP—lung cancer	1.45e-05	0.0012	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—POMC—lung cancer	1.44e-05	0.00119	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFC—lung cancer	1.4e-05	0.00117	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2E1—lung cancer	1.38e-05	0.00115	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NQO1—lung cancer	1.37e-05	0.00114	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.34e-05	0.00111	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP2—lung cancer	1.34e-05	0.00111	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—HRAS—lung cancer	1.33e-05	0.00111	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADCY1—lung cancer	1.33e-05	0.0011	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.32e-05	0.0011	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PPP2R1B—lung cancer	1.29e-05	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SMARCA4—lung cancer	1.29e-05	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HSPB1—lung cancer	1.25e-05	0.00104	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTHLH—lung cancer	1.23e-05	0.00103	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—STK11—lung cancer	1.23e-05	0.00102	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ANXA1—lung cancer	1.16e-05	0.000964	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.16e-05	0.000961	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTP1—lung cancer	1.14e-05	0.000947	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FLT1—lung cancer	1.12e-05	0.000934	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CG—lung cancer	1.11e-05	0.000925	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CXCL8—lung cancer	1.11e-05	0.000924	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CAT—lung cancer	1.11e-05	0.000922	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.1e-05	0.000917	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH3—lung cancer	1.1e-05	0.000914	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APP—lung cancer	1.1e-05	0.000914	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF9—lung cancer	1.09e-05	0.000907	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCB1—lung cancer	1.08e-05	0.000897	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TYMS—lung cancer	1.06e-05	0.000881	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—POMC—lung cancer	1.06e-05	0.000881	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTM1—lung cancer	1.05e-05	0.000871	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JUNB—lung cancer	1.04e-05	0.000866	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	1.01e-05	0.00084	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP1A1—lung cancer	9.92e-06	0.000825	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ERCC2—lung cancer	9.84e-06	0.000818	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	9.78e-06	0.000813	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—POMC—lung cancer	9.61e-06	0.0008	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STK11—lung cancer	9.45e-06	0.000786	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6R—lung cancer	9.38e-06	0.00078	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FOXO3—lung cancer	9.12e-06	0.000759	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	8.94e-06	0.000743	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	8.88e-06	0.000738	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AVP—lung cancer	8.55e-06	0.000711	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	8.52e-06	0.000709	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOA1—lung cancer	8.51e-06	0.000708	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1R—lung cancer	8.23e-06	0.000684	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	8.19e-06	0.000681	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.15e-06	0.000678	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HES1—lung cancer	8.08e-06	0.000672	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RAF1—lung cancer	7.93e-06	0.000659	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IL2—lung cancer	7.83e-06	0.000651	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CG—lung cancer	7.77e-06	0.000646	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	7.74e-06	0.000644	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL8—lung cancer	7.44e-06	0.000619	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—POMC—lung cancer	7.4e-06	0.000615	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB3—lung cancer	7.39e-06	0.000615	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CREBBP—lung cancer	7.2e-06	0.000599	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL2—lung cancer	7.11e-06	0.000591	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TERT—lung cancer	7.08e-06	0.000589	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGFR1—lung cancer	6.88e-06	0.000572	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CD—lung cancer	6.83e-06	0.000568	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIF1A—lung cancer	6.77e-06	0.000563	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALB—lung cancer	6.74e-06	0.000561	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOA1—lung cancer	6.53e-06	0.000544	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KDR—lung cancer	6.48e-06	0.000539	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APC—lung cancer	5.97e-06	0.000496	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CG—lung cancer	5.97e-06	0.000496	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KIT—lung cancer	5.97e-06	0.000496	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—NRAS—lung cancer	5.97e-06	0.000496	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CB—lung cancer	5.95e-06	0.000495	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTGS2—lung cancer	5.9e-06	0.000491	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGF—lung cancer	5.9e-06	0.000491	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAPK3—lung cancer	5.71e-06	0.000475	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—POMC—lung cancer	5.68e-06	0.000472	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BRAF—lung cancer	5.61e-06	0.000466	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6R—lung cancer	5.54e-06	0.000461	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CREBBP—lung cancer	5.53e-06	0.00046	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EGFR—lung cancer	5.44e-06	0.000452	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAP2K1—lung cancer	5.28e-06	0.000439	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CD—lung cancer	5.24e-06	0.000436	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	5.19e-06	0.000432	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTEN—lung cancer	5.15e-06	0.000428	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—KRAS—lung cancer	5.13e-06	0.000427	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—EP300—lung cancer	4.91e-06	0.000408	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	4.72e-06	0.000392	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MDM2—lung cancer	4.7e-06	0.000391	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RAF1—lung cancer	4.68e-06	0.000389	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB2—lung cancer	4.63e-06	0.000385	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MTOR—lung cancer	4.57e-06	0.00038	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CB—lung cancer	4.57e-06	0.00038	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL8—lung cancer	4.39e-06	0.000365	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HRAS—lung cancer	4.36e-06	0.000363	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT1—lung cancer	4.24e-06	0.000353	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP3—lung cancer	4.2e-06	0.00035	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL2—lung cancer	4.2e-06	0.000349	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—lung cancer	4.18e-06	0.000347	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCND1—lung cancer	4.09e-06	0.00034	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JUN—lung cancer	4.08e-06	0.00034	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP9—lung cancer	3.97e-06	0.000331	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1A—lung cancer	3.96e-06	0.000329	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTEN—lung cancer	3.95e-06	0.000329	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT1—lung cancer	3.85e-06	0.000321	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EP300—lung cancer	3.77e-06	0.000313	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SRC—lung cancer	3.66e-06	0.000305	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CA—lung cancer	3.63e-06	0.000302	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—lung cancer	3.57e-06	0.000297	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT3—lung cancer	3.53e-06	0.000294	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NRAS—lung cancer	3.52e-06	0.000293	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK3—lung cancer	3.38e-06	0.000281	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MYC—lung cancer	3.28e-06	0.000273	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGFR—lung cancer	3.21e-06	0.000267	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KRAS—lung cancer	3.03e-06	0.000252	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKT1—lung cancer	2.97e-06	0.000247	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CA—lung cancer	2.79e-06	0.000232	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TP53—lung cancer	2.7e-06	0.000224	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HRAS—lung cancer	2.58e-06	0.000214	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—lung cancer	2.47e-06	0.000205	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT1—lung cancer	2.28e-06	0.000189	CbGpPWpGaD
